{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:16Z","timestamp":1786982176902,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12012-020-09616-z","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T12:06:21Z","timestamp":1604059581000},"page":"248-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Divergent Electrophysiological Effects of Loperamide and Naloxone in a Sensitive Whole-Heart Model"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9344-7826","authenticated-orcid":false,"given":"Julian","family":"Wolfes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ellermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Burde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Leitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"B\u00f6geholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Willy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Reinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Frommeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"issue":"1\u20133","key":"9616_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.drugalcdep.2012.11.003","volume":"130","author":"R Daniulaityte","year":"2013","unstructured":"Daniulaityte, R., Carlson, R., Falck, R., Cameron, D., Perera, S., Chen, L., et al. (2013). \u201cI just wanted to tell you that loperamide WILL WORK\u201d: A web-based study of extra-medical use of loperamide. Drug and Alcohol Dependence, 130(1\u20133), 241\u2013244.","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"9616_CR2","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1111\/jce.14129","volume":"30","author":"T Teigeler","year":"2019","unstructured":"Teigeler, T., Stahura, H., Alimohammad, R., Kalahasty, G., Koneru, J. N., Ellenbogen, M., et al. (2019). Electrocardiographic changes in loperamide toxicity: Case report and review of literature. Journal of Cardiovascular Electrophysiology, 30(11), 2618\u20132626.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"10","key":"9616_CR3","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.amjmed.2015.05.019","volume":"128","author":"EO Enakpene","year":"2015","unstructured":"Enakpene, E. O., Riaz, I. B., Shirazi, F. M., Raz, Y., & Indik, J. H. (2015). The long QT teaser: Loperamide abuse. American Journal of Medicine, 128(10), 1083\u20131086.","journal-title":"American Journal of Medicine"},{"issue":"10","key":"9616_CR4","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/jce.13052","volume":"27","author":"P Vaughn","year":"2016","unstructured":"Vaughn, P., Solik, M. M., Bagga, S., & Padanilam, B. J. (2016). Electrocardiographic abnormalities, malignant ventricular arrhythmias, and cardiomyopathy associated with loperamide abuse. Journal of Cardiovascular Electrophysiology, 27(10), 1230\u20131233.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"2","key":"9616_CR5","doi-asserted-by":"publisher","first-page":"e232823","DOI":"10.1136\/bcr-2019-232823","volume":"13","author":"KK Sahu","year":"2020","unstructured":"Sahu, K. K., El Meligy, A., Mishra, A. K., & Goyal, S. (2020). A tale of twists: Loperamide-induced torsades de pointes and ventricular tachycardia storm. BMJ Case Reports, 13(2), e232823.","journal-title":"BMJ Case Reports"},{"issue":"10","key":"9616_CR6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00210-016-1286-7","volume":"389","author":"J Kang","year":"2016","unstructured":"Kang, J., Compton, D. R., Vaz, R. J., & Rampe, D. (2016). Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: Revelations from the opioid abuse epidemic. Naunyn Schmiedebergs Arch Pharmacol., 389(10), 1133\u20131137.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"issue":"2","key":"9616_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1476-5381.2011.01415.x","volume":"164","author":"AR Harmer","year":"2011","unstructured":"Harmer, A. R., Valentin, J. P., & Pollard, C. E. (2011). On the relationship between block of the cardiac Na(+) channel and drug-induced prolongation of the QRS complex. British Journal of Pharmacology, 164(2), 260\u2013273.","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"9616_CR8","first-page":"747","volume":"45","author":"J Church","year":"1994","unstructured":"Church, J., Fletcher, E. J., Abdel-Hamid, K., & MacDonald, J. F. (1994). Loperamide blocks high-voltage-activated calcium channels and N-methyl-d-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurons. Molecular Pharmacology, 45(4), 747\u2013757.","journal-title":"Molecular Pharmacology"},{"issue":"4","key":"9616_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0168-0102(03)00126-3","volume":"46","author":"K Hagiwara","year":"2003","unstructured":"Hagiwara, K., Nakagawasai, O., Murata, A., Yamadera, F., Miyoshi, I., Tan-No, K., et al. (2003). Analgesic action of loperamide, an opioid agonist, and its blocking action on voltage-dependent Ca2+ channels. Neuroscience Research, 46(4), 493\u2013497.","journal-title":"Neuroscience Research"},{"key":"9616_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.phrs.2015.04.011","volume":"97","author":"MK Pugsley","year":"2015","unstructured":"Pugsley, M. K., Hayes, E. S., Wang, W. Q., & Walker, M. J. (2015). Ventricular arrhythmia incidence in the rat is reduced by naloxone. Pharmacological Research, 97, 64\u201369.","journal-title":"Pharmacological Research"},{"issue":"4","key":"9616_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1124\/mol.118.114751","volume":"95","author":"JN Tschirhart","year":"2019","unstructured":"Tschirhart, J. N., Li, W., Guo, J., & Zhang, S. (2019). Blockade of the Human Ether A-Go-Go-Related Gene (hERG) potassium channel by fentanyl. Molecular Pharmacology, 95(4), 386\u2013397.","journal-title":"Molecular Pharmacology"},{"issue":"2","key":"9616_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/cvr\/27.2.296","volume":"27","author":"KG Oldroyd","year":"1993","unstructured":"Oldroyd, K. G., Hicks, M. N., & Cobbe, S. M. (1993). Influence of hyperkalaemia and ischaemia on non-receptor-mediated cardiac electrophysiological effects of naloxone. Cardiovascular Research, 27(2), 296\u2013303.","journal-title":"Cardiovascular Research"},{"issue":"1","key":"9616_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1161\/01.CIR.0000109484.00668.CE","volume":"109","author":"B Drolet","year":"2004","unstructured":"Drolet, B., Simard, C., & Roden, D. M. (2004). Unusual effects of a QT-prolonging drug, arsenic trioxide, on cardiac potassium currents. Circulation, 109(1), 26\u201329.","journal-title":"Circulation"},{"issue":"10","key":"9616_CR14","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/jce.13029","volume":"27","author":"G Frommeyer","year":"2016","unstructured":"Frommeyer, G., Ellermann, C., Dechering, D. G., Kochhauser, S., Bogeholz, N., Guner, F., et al. (2016). Ranolazine and vernakalant prevent ventricular arrhythmias in an experimental whole-heart model of short QT syndrome. Journal of Cardiovascular Electrophysiology, 27(10), 1214\u20131219.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"6","key":"9616_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/ADM.0000000000000440","volume":"12","author":"A Okusanya","year":"2018","unstructured":"Okusanya, A., & Li, X. (2018). Loperamide abuse and dependence: Clinical features and treatment considerations. Journal of Addiction Medicine, 12(6), 496\u2013498.","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"9616_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.annemergmed.2016.03.047","volume":"69","author":"W Eggleston","year":"2017","unstructured":"Eggleston, W., Clark, K. H., & Marraffa, J. M. (2017). Loperamide abuse associated with cardiac dysrhythmia and death. Annals of Emergency Medicine, 69(1), 83\u201386.","journal-title":"Annals of Emergency Medicine"},{"issue":"5","key":"9616_CR17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3109\/15563650.2016.1159310","volume":"54","author":"RS Wightman","year":"2016","unstructured":"Wightman, R. S., Hoffman, R. S., Howland, M. A., Rice, B., Biary, R., & Lugassy, D. (2016). Not your regular high: Cardiac dysrhythmias caused by loperamide. Clinical Toxicology (Philadelphia, PA), 54(5), 454\u2013458.","journal-title":"Clinical Toxicology (Philadelphia, PA)"},{"issue":"3","key":"9616_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/add.14033","volume":"113","author":"R McDonald","year":"2018","unstructured":"McDonald, R., Lorch, U., Woodward, J., Bosse, B., Dooner, H., Mundin, G., et al. (2018). Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: Phase I healthy volunteer study. Addiction, 113(3), 484\u2013493.","journal-title":"Addiction"},{"issue":"3","key":"9616_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12012-018-9494-7","volume":"19","author":"C Ellermann","year":"2019","unstructured":"Ellermann, C., Wolfes, J., Puckhaber, D., Bogeholz, N., Leitz, P., Lange, P. S., et al. (2019). Digitalis promotes ventricular arrhythmias in flecainide- and ranolazine-pretreated hearts. Cardiovascular Toxicology, 19(3), 237\u2013243.","journal-title":"Cardiovascular Toxicology"},{"issue":"2","key":"9616_CR20","doi-asserted-by":"publisher","first-page":"e0172683","DOI":"10.1371\/journal.pone.0172683","volume":"12","author":"OE Osadchii","year":"2017","unstructured":"Osadchii, O. E. (2017). Effects of Na+ channel blockers on the restitution of refractory period, conduction time, and excitation wavelength in perfused guinea-pig heart. PLoS ONE, 12(2), e0172683.","journal-title":"PLoS ONE"},{"issue":"8","key":"9616_CR21","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/europace\/eux221","volume":"20","author":"G Frommeyer","year":"2018","unstructured":"Frommeyer, G., Garthmann, J., Ellermann, C., Dechering, D. G., Kochhauser, S., Reinke, F., et al. (2018). Broad antiarrhythmic effect of mexiletine in different arrhythmia models. Europace, 20(8), 1375\u20131381.","journal-title":"Europace"},{"issue":"3","key":"9616_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.vascn.2004.03.008","volume":"49","author":"JP Valentin","year":"2004","unstructured":"Valentin, J. P., Hoffmann, P., De Clerck, F., Hammond, T. G., & Hondeghem, L. (2004). Review of the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs. Journal of Pharmacological and Toxicological Methods, 49(3), 171\u2013181.","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"9","key":"9616_CR23","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3109\/15563650.2014.969371","volume":"52","author":"JM Marraffa","year":"2014","unstructured":"Marraffa, J. M., Holland, M. G., Sullivan, R. W., Morgan, B. W., Oakes, J. A., Wiegand, T. J., et al. (2014). Cardiac conduction disturbance after loperamide abuse. Clinical Toxicology (Philadelphia, PA), 52(9), 952\u2013957.","journal-title":"Clinical Toxicology (Philadelphia, PA)"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-020-09616-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-020-09616-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-020-09616-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T06:10:10Z","timestamp":1612073410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-020-09616-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["9616"],"URL":"https:\/\/doi.org\/10.1007\/s12012-020-09616-z","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"25 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors report no relationships that could be construed as a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution at which the studies were conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}